nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Lacosamide—epilepsy syndrome	0.351	1	CrCtD
Amphetamine—SLC6A4—epilepsy syndrome	0.0683	0.587	CbGaD
Amphetamine—CYP2D6—epilepsy syndrome	0.048	0.413	CbGaD
Amphetamine—MAOB—Zonisamide—epilepsy syndrome	0.0381	0.311	CbGbCtD
Amphetamine—Lacosamide—Felbamate—epilepsy syndrome	0.03	0.12	CrCrCtD
Amphetamine—CYP2A6—Amobarbital—epilepsy syndrome	0.0214	0.175	CbGbCtD
Amphetamine—Phenformin—Lacosamide—epilepsy syndrome	0.0203	0.0815	CrCrCtD
Amphetamine—Phenacemide—Felbamate—epilepsy syndrome	0.0203	0.0815	CrCrCtD
Amphetamine—Lisdexamfetamine—Lacosamide—epilepsy syndrome	0.0203	0.0815	CrCrCtD
Amphetamine—Nateglinide—Lacosamide—epilepsy syndrome	0.0181	0.0727	CrCrCtD
Amphetamine—Aspartame—Lacosamide—epilepsy syndrome	0.0172	0.069	CrCrCtD
Amphetamine—CYP2A6—Propofol—epilepsy syndrome	0.016	0.131	CbGbCtD
Amphetamine—Bethanidine—Lacosamide—epilepsy syndrome	0.0157	0.0628	CrCrCtD
Amphetamine—CYP2A6—Phenobarbital—epilepsy syndrome	0.0153	0.125	CbGbCtD
Amphetamine—SLC22A5—Valproic Acid—epilepsy syndrome	0.015	0.123	CbGbCtD
Amphetamine—Mephentermine—Lacosamide—epilepsy syndrome	0.015	0.0601	CrCrCtD
Amphetamine—L-Phenylalanine—Felbamate—epilepsy syndrome	0.015	0.0601	CrCrCtD
Amphetamine—Phenelzine—Lacosamide—epilepsy syndrome	0.0144	0.0577	CrCrCtD
Amphetamine—Phentermine—Lacosamide—epilepsy syndrome	0.0138	0.0555	CrCrCtD
Amphetamine—Phenacemide—Lacosamide—epilepsy syndrome	0.0117	0.0468	CrCrCtD
Amphetamine—CYP2A6—Valproic Acid—epilepsy syndrome	0.0114	0.0934	CbGbCtD
Amphetamine—Dextroamphetamine—Lacosamide—epilepsy syndrome	0.0113	0.0454	CrCrCtD
Amphetamine—Methamphetamine—Lacosamide—epilepsy syndrome	0.011	0.0441	CrCrCtD
Amphetamine—L-Phenylalanine—Lacosamide—epilepsy syndrome	0.00861	0.0345	CrCrCtD
Amphetamine—Benzphetamine—Phenytoin—epilepsy syndrome	0.0066	0.0265	CrCrCtD
Amphetamine—CYP2D6—Propofol—epilepsy syndrome	0.00502	0.0411	CbGbCtD
Amphetamine—CARTPT—telencephalic ventricle—epilepsy syndrome	0.00337	0.105	CbGeAlD
Amphetamine—CARTPT—hindbrain—epilepsy syndrome	0.00159	0.0494	CbGeAlD
Amphetamine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00147	0.0458	CbGeAlD
Amphetamine—SLC18A2—telencephalic ventricle—epilepsy syndrome	0.00114	0.0356	CbGeAlD
Amphetamine—CARTPT—brainstem—epilepsy syndrome	0.000912	0.0283	CbGeAlD
Amphetamine—CARTPT—forebrain—epilepsy syndrome	0.00088	0.0273	CbGeAlD
Amphetamine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000866	0.0269	CbGeAlD
Amphetamine—CARTPT—telencephalon—epilepsy syndrome	0.000809	0.0251	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000783	0.0243	CbGeAlD
Amphetamine—SLC18A2—ganglion—epilepsy syndrome	0.000713	0.0221	CbGeAlD
Amphetamine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000637	0.0198	CbGeAlD
Amphetamine—CARTPT—medulla oblongata—epilepsy syndrome	0.000636	0.0198	CbGeAlD
Amphetamine—CARTPT—spinal cord—epilepsy syndrome	0.000567	0.0176	CbGeAlD
Amphetamine—SLC6A3—ganglion—epilepsy syndrome	0.000539	0.0167	CbGeAlD
Amphetamine—CARTPT—head—epilepsy syndrome	0.000504	0.0157	CbGeAlD
Amphetamine—SLC22A3—tongue—epilepsy syndrome	0.000502	0.0156	CbGeAlD
Amphetamine—SLC6A4—ganglion—epilepsy syndrome	0.000494	0.0153	CbGeAlD
Amphetamine—TAAR1—nervous system—epilepsy syndrome	0.000478	0.0148	CbGeAlD
Amphetamine—CARTPT—nervous system—epilepsy syndrome	0.000478	0.0148	CbGeAlD
Amphetamine—MAOB—ganglion—epilepsy syndrome	0.00047	0.0146	CbGeAlD
Amphetamine—TAAR1—central nervous system—epilepsy syndrome	0.00046	0.0143	CbGeAlD
Amphetamine—CARTPT—central nervous system—epilepsy syndrome	0.00046	0.0143	CbGeAlD
Amphetamine—CARTPT—cerebellum—epilepsy syndrome	0.00045	0.014	CbGeAlD
Amphetamine—SLC6A2—ganglion—epilepsy syndrome	0.000435	0.0135	CbGeAlD
Amphetamine—SLC6A3—hindbrain—epilepsy syndrome	0.000409	0.0127	CbGeAlD
Amphetamine—DRD2—ganglion—epilepsy syndrome	0.000396	0.0123	CbGeAlD
Amphetamine—SLC6A4—hindbrain—epilepsy syndrome	0.000375	0.0116	CbGeAlD
Amphetamine—CARTPT—brain—epilepsy syndrome	0.000365	0.0113	CbGeAlD
Amphetamine—MAOB—hindbrain—epilepsy syndrome	0.000356	0.0111	CbGeAlD
Amphetamine—SLC18A2—brainstem—epilepsy syndrome	0.00031	0.00963	CbGeAlD
Amphetamine—DRD2—hindbrain—epilepsy syndrome	0.000301	0.00934	CbGeAlD
Amphetamine—SLC18A2—forebrain—epilepsy syndrome	0.000299	0.00929	CbGeAlD
Amphetamine—SLC18A2—telencephalon—epilepsy syndrome	0.000275	0.00854	CbGeAlD
Amphetamine—SLC6A3—brainstem—epilepsy syndrome	0.000234	0.00728	CbGeAlD
Amphetamine—SLC6A3—forebrain—epilepsy syndrome	0.000226	0.00703	CbGeAlD
Amphetamine—SLC18A2—medulla oblongata—epilepsy syndrome	0.000216	0.00671	CbGeAlD
Amphetamine—Phenacemide—SCN1A—epilepsy syndrome	0.000215	0.118	CrCbGaD
Amphetamine—SLC6A4—brainstem—epilepsy syndrome	0.000215	0.00667	CbGeAlD
Amphetamine—SLC6A3—telencephalon—epilepsy syndrome	0.000208	0.00646	CbGeAlD
Amphetamine—SLC6A4—forebrain—epilepsy syndrome	0.000207	0.00644	CbGeAlD
Amphetamine—MAOB—brainstem—epilepsy syndrome	0.000204	0.00634	CbGeAlD
Amphetamine—SLC18A2—midbrain—epilepsy syndrome	0.000197	0.00613	CbGeAlD
Amphetamine—MAOB—forebrain—epilepsy syndrome	0.000197	0.00612	CbGeAlD
Amphetamine—Aspartame—TRPV1—epilepsy syndrome	0.000191	0.105	CrCbGaD
Amphetamine—SLC6A4—telencephalon—epilepsy syndrome	0.000191	0.00592	CbGeAlD
Amphetamine—SLC6A2—brainstem—epilepsy syndrome	0.000189	0.00587	CbGeAlD
Amphetamine—SLC6A2—forebrain—epilepsy syndrome	0.000182	0.00567	CbGeAlD
Amphetamine—MAOB—telencephalon—epilepsy syndrome	0.000181	0.00563	CbGeAlD
Amphetamine—CYP2D6—hindbrain—epilepsy syndrome	0.000181	0.00561	CbGeAlD
Amphetamine—DRD2—brainstem—epilepsy syndrome	0.000172	0.00535	CbGeAlD
Amphetamine—SLC18A2—head—epilepsy syndrome	0.000171	0.00532	CbGeAlD
Amphetamine—SLC6A2—telencephalon—epilepsy syndrome	0.000168	0.00521	CbGeAlD
Amphetamine—DRD2—forebrain—epilepsy syndrome	0.000166	0.00517	CbGeAlD
Amphetamine—SLC18A2—nervous system—epilepsy syndrome	0.000162	0.00504	CbGeAlD
Amphetamine—SLC18A2—central nervous system—epilepsy syndrome	0.000156	0.00486	CbGeAlD
Amphetamine—DRD2—telencephalon—epilepsy syndrome	0.000153	0.00475	CbGeAlD
Amphetamine—SLC18A2—cerebellum—epilepsy syndrome	0.000153	0.00475	CbGeAlD
Amphetamine—SLC6A3—midbrain—epilepsy syndrome	0.000149	0.00464	CbGeAlD
Amphetamine—Lacosamide—SCN9A—epilepsy syndrome	0.000149	0.0817	CrCbGaD
Amphetamine—SLC6A3—spinal cord—epilepsy syndrome	0.000146	0.00453	CbGeAlD
Amphetamine—Lacosamide—SCN3A—epilepsy syndrome	0.000143	0.0782	CrCbGaD
Amphetamine—MAOB—medulla oblongata—epilepsy syndrome	0.000142	0.00442	CbGeAlD
Amphetamine—SLC6A4—midbrain—epilepsy syndrome	0.000137	0.00425	CbGeAlD
Amphetamine—CYP2A6—cerebellum—epilepsy syndrome	0.000136	0.00424	CbGeAlD
Amphetamine—SLC6A4—spinal cord—epilepsy syndrome	0.000134	0.00415	CbGeAlD
Amphetamine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000132	0.0041	CbGeAlD
Amphetamine—MAOB—midbrain—epilepsy syndrome	0.00013	0.00404	CbGeAlD
Amphetamine—Phenelzine—ABAT—epilepsy syndrome	0.00013	0.0714	CrCbGaD
Amphetamine—SLC6A3—head—epilepsy syndrome	0.00013	0.00402	CbGeAlD
Amphetamine—MAOB—spinal cord—epilepsy syndrome	0.000127	0.00394	CbGeAlD
Amphetamine—SLC18A2—brain—epilepsy syndrome	0.000124	0.00385	CbGeAlD
Amphetamine—SLC6A3—nervous system—epilepsy syndrome	0.000123	0.00381	CbGeAlD
Amphetamine—SLC22A3—head—epilepsy syndrome	0.000122	0.00379	CbGeAlD
Amphetamine—SLC6A4—head—epilepsy syndrome	0.000119	0.00369	CbGeAlD
Amphetamine—SLC6A3—central nervous system—epilepsy syndrome	0.000118	0.00367	CbGeAlD
Amphetamine—SLC22A3—nervous system—epilepsy syndrome	0.000116	0.00359	CbGeAlD
Amphetamine—SLC6A3—cerebellum—epilepsy syndrome	0.000116	0.00359	CbGeAlD
Amphetamine—MAOB—head—epilepsy syndrome	0.000113	0.00351	CbGeAlD
Amphetamine—SLC6A4—nervous system—epilepsy syndrome	0.000113	0.0035	CbGeAlD
Amphetamine—SLC22A5—medulla oblongata—epilepsy syndrome	0.000112	0.00348	CbGeAlD
Amphetamine—SLC22A3—central nervous system—epilepsy syndrome	0.000111	0.00346	CbGeAlD
Amphetamine—CYP2A6—brain—epilepsy syndrome	0.000111	0.00344	CbGeAlD
Amphetamine—DRD2—midbrain—epilepsy syndrome	0.00011	0.00341	CbGeAlD
Amphetamine—SLC6A4—central nervous system—epilepsy syndrome	0.000108	0.00337	CbGeAlD
Amphetamine—MAOB—nervous system—epilepsy syndrome	0.000107	0.00332	CbGeAlD
Amphetamine—SLC6A2—head—epilepsy syndrome	0.000104	0.00325	CbGeAlD
Amphetamine—CYP2D6—brainstem—epilepsy syndrome	0.000104	0.00322	CbGeAlD
Amphetamine—MAOB—central nervous system—epilepsy syndrome	0.000103	0.0032	CbGeAlD
Amphetamine—SLC22A5—midbrain—epilepsy syndrome	0.000102	0.00318	CbGeAlD
Amphetamine—MAOB—cerebellum—epilepsy syndrome	0.000101	0.00313	CbGeAlD
Amphetamine—CYP2D6—forebrain—epilepsy syndrome	9.99e-05	0.0031	CbGeAlD
Amphetamine—SLC22A5—spinal cord—epilepsy syndrome	9.98e-05	0.0031	CbGeAlD
Amphetamine—SLC6A2—nervous system—epilepsy syndrome	9.91e-05	0.00308	CbGeAlD
Amphetamine—L-Phenylalanine—TH—epilepsy syndrome	9.81e-05	0.0538	CrCbGaD
Amphetamine—SLC6A2—central nervous system—epilepsy syndrome	9.54e-05	0.00296	CbGeAlD
Amphetamine—DRD2—head—epilepsy syndrome	9.52e-05	0.00296	CbGeAlD
Amphetamine—SLC6A3—brain—epilepsy syndrome	9.38e-05	0.00292	CbGeAlD
Amphetamine—Lacosamide—CA4—epilepsy syndrome	9.38e-05	0.0515	CrCbGaD
Amphetamine—CYP2D6—telencephalon—epilepsy syndrome	9.19e-05	0.00285	CbGeAlD
Amphetamine—DRD2—nervous system—epilepsy syndrome	9.03e-05	0.0028	CbGeAlD
Amphetamine—SLC22A3—brain—epilepsy syndrome	8.84e-05	0.00275	CbGeAlD
Amphetamine—DRD2—central nervous system—epilepsy syndrome	8.69e-05	0.0027	CbGeAlD
Amphetamine—SLC6A4—brain—epilepsy syndrome	8.6e-05	0.00267	CbGeAlD
Amphetamine—DRD2—cerebellum—epilepsy syndrome	8.49e-05	0.00264	CbGeAlD
Amphetamine—MAOB—brain—epilepsy syndrome	8.18e-05	0.00254	CbGeAlD
Amphetamine—SLC22A5—cerebellum—epilepsy syndrome	7.91e-05	0.00246	CbGeAlD
Amphetamine—SLC6A2—brain—epilepsy syndrome	7.57e-05	0.00235	CbGeAlD
Amphetamine—Nateglinide—KCNJ11—epilepsy syndrome	7.05e-05	0.0387	CrCbGaD
Amphetamine—DRD2—brain—epilepsy syndrome	6.9e-05	0.00214	CbGeAlD
Amphetamine—SLC22A5—brain—epilepsy syndrome	6.42e-05	0.002	CbGeAlD
Amphetamine—CYP2D6—head—epilepsy syndrome	5.72e-05	0.00178	CbGeAlD
Amphetamine—Tolazoline—ADRA2A—epilepsy syndrome	5.68e-05	0.0312	CrCbGaD
Amphetamine—CYP2D6—nervous system—epilepsy syndrome	5.42e-05	0.00168	CbGeAlD
Amphetamine—Ephedrine—BCHE—epilepsy syndrome	5.41e-05	0.0297	CrCbGaD
Amphetamine—CYP2D6—central nervous system—epilepsy syndrome	5.22e-05	0.00162	CbGeAlD
Amphetamine—CYP2D6—cerebellum—epilepsy syndrome	5.1e-05	0.00159	CbGeAlD
Amphetamine—Phenylpropanolamine—ADRA2A—epilepsy syndrome	4.97e-05	0.0273	CrCbGaD
Amphetamine—Constipation—Lamotrigine—epilepsy syndrome	4.24e-05	0.000555	CcSEcCtD
Amphetamine—Nervousness—Pregabalin—epilepsy syndrome	4.24e-05	0.000555	CcSEcCtD
Amphetamine—Nausea—Acetazolamide—epilepsy syndrome	4.24e-05	0.000555	CcSEcCtD
Amphetamine—Dizziness—Levetiracetam—epilepsy syndrome	4.23e-05	0.000554	CcSEcCtD
Amphetamine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	4.23e-05	0.000554	CcSEcCtD
Amphetamine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	4.23e-05	0.000554	CcSEcCtD
Amphetamine—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.23e-05	0.000554	CcSEcCtD
Amphetamine—Vomiting—Propofol—epilepsy syndrome	4.21e-05	0.000552	CcSEcCtD
Amphetamine—Pseudoephedrine—ADRA2A—epilepsy syndrome	4.2e-05	0.023	CrCbGaD
Amphetamine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	4.2e-05	0.00055	CcSEcCtD
Amphetamine—Urinary tract infection—Topiramate—epilepsy syndrome	4.19e-05	0.000549	CcSEcCtD
Amphetamine—Rash—Propofol—epilepsy syndrome	4.18e-05	0.000547	CcSEcCtD
Amphetamine—Dermatitis—Propofol—epilepsy syndrome	4.17e-05	0.000547	CcSEcCtD
Amphetamine—Hypertension—Valproic Acid—epilepsy syndrome	4.17e-05	0.000546	CcSEcCtD
Amphetamine—Headache—Propofol—epilepsy syndrome	4.15e-05	0.000543	CcSEcCtD
Amphetamine—CYP2D6—brain—epilepsy syndrome	4.15e-05	0.00129	CbGeAlD
Amphetamine—Hypersensitivity—Zonisamide—epilepsy syndrome	4.14e-05	0.000542	CcSEcCtD
Amphetamine—Vomiting—Midazolam—epilepsy syndrome	4.12e-05	0.00054	CcSEcCtD
Amphetamine—Diarrhoea—Vigabatrin—epilepsy syndrome	4.12e-05	0.00054	CcSEcCtD
Amphetamine—Asthenia—Felbamate—epilepsy syndrome	4.12e-05	0.000539	CcSEcCtD
Amphetamine—Chest pain—Valproic Acid—epilepsy syndrome	4.11e-05	0.000538	CcSEcCtD
Amphetamine—Anxiety—Valproic Acid—epilepsy syndrome	4.1e-05	0.000537	CcSEcCtD
Amphetamine—Tremor—Pregabalin—epilepsy syndrome	4.09e-05	0.000536	CcSEcCtD
Amphetamine—Rash—Midazolam—epilepsy syndrome	4.09e-05	0.000535	CcSEcCtD
Amphetamine—Dizziness—Fosphenytoin—epilepsy syndrome	4.08e-05	0.000535	CcSEcCtD
Amphetamine—Dermatitis—Midazolam—epilepsy syndrome	4.08e-05	0.000535	CcSEcCtD
Amphetamine—Urticaria—Carbamazepine—epilepsy syndrome	4.08e-05	0.000534	CcSEcCtD
Amphetamine—Vomiting—Levetiracetam—epilepsy syndrome	4.07e-05	0.000533	CcSEcCtD
Amphetamine—Headache—Midazolam—epilepsy syndrome	4.06e-05	0.000532	CcSEcCtD
Amphetamine—Body temperature increased—Carbamazepine—epilepsy syndrome	4.06e-05	0.000531	CcSEcCtD
Amphetamine—Abdominal pain—Carbamazepine—epilepsy syndrome	4.06e-05	0.000531	CcSEcCtD
Amphetamine—Diarrhoea—Diazepam—epilepsy syndrome	4.06e-05	0.000531	CcSEcCtD
Amphetamine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	4.06e-05	0.000531	CcSEcCtD
Amphetamine—Rash—Levetiracetam—epilepsy syndrome	4.04e-05	0.000529	CcSEcCtD
Amphetamine—Dermatitis—Levetiracetam—epilepsy syndrome	4.03e-05	0.000528	CcSEcCtD
Amphetamine—Asthenia—Zonisamide—epilepsy syndrome	4.03e-05	0.000528	CcSEcCtD
Amphetamine—Dry mouth—Valproic Acid—epilepsy syndrome	4.02e-05	0.000527	CcSEcCtD
Amphetamine—Agitation—Pregabalin—epilepsy syndrome	4.01e-05	0.000525	CcSEcCtD
Amphetamine—Headache—Levetiracetam—epilepsy syndrome	4.01e-05	0.000525	CcSEcCtD
Amphetamine—Angioedema—Pregabalin—epilepsy syndrome	3.99e-05	0.000522	CcSEcCtD
Amphetamine—Hypersensitivity—Clonazepam—epilepsy syndrome	3.99e-05	0.000522	CcSEcCtD
Amphetamine—Dizziness—Vigabatrin—epilepsy syndrome	3.98e-05	0.000521	CcSEcCtD
Amphetamine—Pseudoephedrine—TNF—epilepsy syndrome	3.98e-05	0.0218	CrCbGaD
Amphetamine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.96e-05	0.000519	CcSEcCtD
Amphetamine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.94e-05	0.000516	CcSEcCtD
Amphetamine—Urticaria—Lamotrigine—epilepsy syndrome	3.94e-05	0.000516	CcSEcCtD
Amphetamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.94e-05	0.000516	CcSEcCtD
Amphetamine—Nausea—Propofol—epilepsy syndrome	3.93e-05	0.000515	CcSEcCtD
Amphetamine—Tension—Gabapentin—epilepsy syndrome	3.93e-05	0.000514	CcSEcCtD
Amphetamine—Vomiting—Fosphenytoin—epilepsy syndrome	3.93e-05	0.000514	CcSEcCtD
Amphetamine—Diarrhoea—Felbamate—epilepsy syndrome	3.93e-05	0.000514	CcSEcCtD
Amphetamine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.92e-05	0.000513	CcSEcCtD
Amphetamine—Abdominal pain—Lamotrigine—epilepsy syndrome	3.92e-05	0.000513	CcSEcCtD
Amphetamine—Dizziness—Diazepam—epilepsy syndrome	3.92e-05	0.000513	CcSEcCtD
Amphetamine—Infection—Valproic Acid—epilepsy syndrome	3.92e-05	0.000513	CcSEcCtD
Amphetamine—Rash—Fosphenytoin—epilepsy syndrome	3.89e-05	0.00051	CcSEcCtD
Amphetamine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.89e-05	0.00051	CcSEcCtD
Amphetamine—Nervousness—Gabapentin—epilepsy syndrome	3.89e-05	0.000509	CcSEcCtD
Amphetamine—Asthenia—Clonazepam—epilepsy syndrome	3.88e-05	0.000509	CcSEcCtD
Amphetamine—Headache—Fosphenytoin—epilepsy syndrome	3.87e-05	0.000507	CcSEcCtD
Amphetamine—Palpitations—Pregabalin—epilepsy syndrome	3.86e-05	0.000505	CcSEcCtD
Amphetamine—Asthenia—Phenytoin—epilepsy syndrome	3.86e-05	0.000505	CcSEcCtD
Amphetamine—Nausea—Midazolam—epilepsy syndrome	3.85e-05	0.000504	CcSEcCtD
Amphetamine—Tachycardia—Valproic Acid—epilepsy syndrome	3.85e-05	0.000504	CcSEcCtD
Amphetamine—Diarrhoea—Zonisamide—epilepsy syndrome	3.84e-05	0.000503	CcSEcCtD
Amphetamine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.84e-05	0.000502	CcSEcCtD
Amphetamine—Vomiting—Vigabatrin—epilepsy syndrome	3.83e-05	0.000501	CcSEcCtD
Amphetamine—Tranylcypromine—CYP2C19—epilepsy syndrome	3.82e-05	0.021	CrCbGaD
Amphetamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.81e-05	0.000499	CcSEcCtD
Amphetamine—Nausea—Levetiracetam—epilepsy syndrome	3.8e-05	0.000498	CcSEcCtD
Amphetamine—Rash—Vigabatrin—epilepsy syndrome	3.8e-05	0.000497	CcSEcCtD
Amphetamine—Dizziness—Felbamate—epilepsy syndrome	3.79e-05	0.000497	CcSEcCtD
Amphetamine—Dermatitis—Vigabatrin—epilepsy syndrome	3.79e-05	0.000497	CcSEcCtD
Amphetamine—Convulsion—Pregabalin—epilepsy syndrome	3.78e-05	0.000495	CcSEcCtD
Amphetamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.78e-05	0.000495	CcSEcCtD
Amphetamine—Headache—Vigabatrin—epilepsy syndrome	3.77e-05	0.000494	CcSEcCtD
Amphetamine—Hypertension—Pregabalin—epilepsy syndrome	3.77e-05	0.000494	CcSEcCtD
Amphetamine—Vomiting—Diazepam—epilepsy syndrome	3.77e-05	0.000494	CcSEcCtD
Amphetamine—Anorexia—Valproic Acid—epilepsy syndrome	3.76e-05	0.000492	CcSEcCtD
Amphetamine—Tremor—Gabapentin—epilepsy syndrome	3.75e-05	0.000491	CcSEcCtD
Amphetamine—Rash—Diazepam—epilepsy syndrome	3.74e-05	0.000489	CcSEcCtD
Amphetamine—Dermatitis—Diazepam—epilepsy syndrome	3.73e-05	0.000489	CcSEcCtD
Amphetamine—Chest pain—Pregabalin—epilepsy syndrome	3.72e-05	0.000487	CcSEcCtD
Amphetamine—Dizziness—Zonisamide—epilepsy syndrome	3.71e-05	0.000486	CcSEcCtD
Amphetamine—Headache—Diazepam—epilepsy syndrome	3.71e-05	0.000486	CcSEcCtD
Amphetamine—Anxiety—Pregabalin—epilepsy syndrome	3.7e-05	0.000485	CcSEcCtD
Amphetamine—Diarrhoea—Clonazepam—epilepsy syndrome	3.7e-05	0.000485	CcSEcCtD
Amphetamine—Asthenia—Carbamazepine—epilepsy syndrome	3.68e-05	0.000482	CcSEcCtD
Amphetamine—Agitation—Gabapentin—epilepsy syndrome	3.68e-05	0.000482	CcSEcCtD
Amphetamine—Diarrhoea—Phenytoin—epilepsy syndrome	3.68e-05	0.000482	CcSEcCtD
Amphetamine—Nausea—Fosphenytoin—epilepsy syndrome	3.67e-05	0.000481	CcSEcCtD
Amphetamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.000479	CcSEcCtD
Amphetamine—Erythema multiforme—Topiramate—epilepsy syndrome	3.66e-05	0.000479	CcSEcCtD
Amphetamine—Angioedema—Gabapentin—epilepsy syndrome	3.66e-05	0.000479	CcSEcCtD
Amphetamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.65e-05	0.000479	CcSEcCtD
Amphetamine—Vomiting—Felbamate—epilepsy syndrome	3.65e-05	0.000478	CcSEcCtD
Amphetamine—Dry mouth—Pregabalin—epilepsy syndrome	3.63e-05	0.000476	CcSEcCtD
Amphetamine—Rash—Felbamate—epilepsy syndrome	3.62e-05	0.000474	CcSEcCtD
Amphetamine—Dermatitis—Felbamate—epilepsy syndrome	3.61e-05	0.000473	CcSEcCtD
Amphetamine—Headache—Felbamate—epilepsy syndrome	3.59e-05	0.000471	CcSEcCtD
Amphetamine—Dizziness—Clonazepam—epilepsy syndrome	3.58e-05	0.000469	CcSEcCtD
Amphetamine—Nausea—Vigabatrin—epilepsy syndrome	3.58e-05	0.000468	CcSEcCtD
Amphetamine—Vomiting—Zonisamide—epilepsy syndrome	3.57e-05	0.000468	CcSEcCtD
Amphetamine—Insomnia—Valproic Acid—epilepsy syndrome	3.56e-05	0.000467	CcSEcCtD
Amphetamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.56e-05	0.000467	CcSEcCtD
Amphetamine—Asthenia—Lamotrigine—epilepsy syndrome	3.56e-05	0.000466	CcSEcCtD
Amphetamine—Dizziness—Phenytoin—epilepsy syndrome	3.55e-05	0.000466	CcSEcCtD
Amphetamine—Rash—Zonisamide—epilepsy syndrome	3.54e-05	0.000464	CcSEcCtD
Amphetamine—Infection—Pregabalin—epilepsy syndrome	3.54e-05	0.000464	CcSEcCtD
Amphetamine—Palpitations—Gabapentin—epilepsy syndrome	3.54e-05	0.000463	CcSEcCtD
Amphetamine—Dermatitis—Zonisamide—epilepsy syndrome	3.54e-05	0.000463	CcSEcCtD
Amphetamine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.000463	CcSEcCtD
Amphetamine—Nausea—Diazepam—epilepsy syndrome	3.52e-05	0.000461	CcSEcCtD
Amphetamine—Headache—Zonisamide—epilepsy syndrome	3.52e-05	0.000461	CcSEcCtD
Amphetamine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.51e-05	0.00046	CcSEcCtD
Amphetamine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.51e-05	0.00046	CcSEcCtD
Amphetamine—Somnolence—Valproic Acid—epilepsy syndrome	3.5e-05	0.000459	CcSEcCtD
Amphetamine—Tachycardia—Pregabalin—epilepsy syndrome	3.48e-05	0.000455	CcSEcCtD
Amphetamine—Phenformin—CYP2D6—epilepsy syndrome	3.47e-05	0.019	CrCbGaD
Amphetamine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.47e-05	0.000454	CcSEcCtD
Amphetamine—Convulsion—Gabapentin—epilepsy syndrome	3.47e-05	0.000454	CcSEcCtD
Amphetamine—Hypertension—Gabapentin—epilepsy syndrome	3.46e-05	0.000453	CcSEcCtD
Amphetamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.44e-05	0.000451	CcSEcCtD
Amphetamine—Vomiting—Clonazepam—epilepsy syndrome	3.44e-05	0.000451	CcSEcCtD
Amphetamine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.43e-05	0.000449	CcSEcCtD
Amphetamine—Vomiting—Phenytoin—epilepsy syndrome	3.42e-05	0.000448	CcSEcCtD
Amphetamine—Rash—Clonazepam—epilepsy syndrome	3.41e-05	0.000447	CcSEcCtD
Amphetamine—Dermatitis—Clonazepam—epilepsy syndrome	3.41e-05	0.000447	CcSEcCtD
Amphetamine—Chest pain—Gabapentin—epilepsy syndrome	3.41e-05	0.000446	CcSEcCtD
Amphetamine—Nausea—Felbamate—epilepsy syndrome	3.41e-05	0.000446	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.4e-05	0.000446	CcSEcCtD
Amphetamine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.4e-05	0.000445	CcSEcCtD
Amphetamine—Fatigue—Valproic Acid—epilepsy syndrome	3.4e-05	0.000445	CcSEcCtD
Amphetamine—Anxiety—Gabapentin—epilepsy syndrome	3.4e-05	0.000445	CcSEcCtD
Amphetamine—Anorexia—Pregabalin—epilepsy syndrome	3.4e-05	0.000445	CcSEcCtD
Amphetamine—Dizziness—Carbamazepine—epilepsy syndrome	3.39e-05	0.000444	CcSEcCtD
Amphetamine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.39e-05	0.000444	CcSEcCtD
Amphetamine—Headache—Clonazepam—epilepsy syndrome	3.39e-05	0.000444	CcSEcCtD
Amphetamine—Rash—Phenytoin—epilepsy syndrome	3.39e-05	0.000444	CcSEcCtD
Amphetamine—Dermatitis—Phenytoin—epilepsy syndrome	3.39e-05	0.000444	CcSEcCtD
Amphetamine—Phentermine—SLC6A4—epilepsy syndrome	3.38e-05	0.0185	CrCbGaD
Amphetamine—Rash—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000442	CcSEcCtD
Amphetamine—Constipation—Valproic Acid—epilepsy syndrome	3.37e-05	0.000441	CcSEcCtD
Amphetamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000441	CcSEcCtD
Amphetamine—Headache—Phenytoin—epilepsy syndrome	3.37e-05	0.000441	CcSEcCtD
Amphetamine—Headache—Oxcarbazepine—epilepsy syndrome	3.35e-05	0.000439	CcSEcCtD
Amphetamine—Nausea—Zonisamide—epilepsy syndrome	3.34e-05	0.000437	CcSEcCtD
Amphetamine—Dry mouth—Gabapentin—epilepsy syndrome	3.33e-05	0.000437	CcSEcCtD
Amphetamine—Tension—Topiramate—epilepsy syndrome	3.3e-05	0.000433	CcSEcCtD
Amphetamine—Dizziness—Lamotrigine—epilepsy syndrome	3.28e-05	0.00043	CcSEcCtD
Amphetamine—Nervousness—Topiramate—epilepsy syndrome	3.27e-05	0.000428	CcSEcCtD
Amphetamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.27e-05	0.000428	CcSEcCtD
Amphetamine—Vomiting—Carbamazepine—epilepsy syndrome	3.26e-05	0.000427	CcSEcCtD
Amphetamine—Infection—Gabapentin—epilepsy syndrome	3.25e-05	0.000425	CcSEcCtD
Amphetamine—Rash—Carbamazepine—epilepsy syndrome	3.24e-05	0.000424	CcSEcCtD
Amphetamine—Dermatitis—Carbamazepine—epilepsy syndrome	3.23e-05	0.000423	CcSEcCtD
Amphetamine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.22e-05	0.000422	CcSEcCtD
Amphetamine—Insomnia—Pregabalin—epilepsy syndrome	3.22e-05	0.000422	CcSEcCtD
Amphetamine—Nausea—Clonazepam—epilepsy syndrome	3.21e-05	0.000421	CcSEcCtD
Amphetamine—Headache—Carbamazepine—epilepsy syndrome	3.21e-05	0.000421	CcSEcCtD
Amphetamine—Pseudoephedrine—SLC6A4—epilepsy syndrome	3.2e-05	0.0176	CrCbGaD
Amphetamine—Nausea—Phenytoin—epilepsy syndrome	3.19e-05	0.000418	CcSEcCtD
Amphetamine—Tachycardia—Gabapentin—epilepsy syndrome	3.19e-05	0.000418	CcSEcCtD
Amphetamine—Dyspnoea—Pregabalin—epilepsy syndrome	3.18e-05	0.000416	CcSEcCtD
Amphetamine—Nausea—Oxcarbazepine—epilepsy syndrome	3.18e-05	0.000416	CcSEcCtD
Amphetamine—Somnolence—Pregabalin—epilepsy syndrome	3.17e-05	0.000415	CcSEcCtD
Amphetamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.16e-05	0.000414	CcSEcCtD
Amphetamine—Tremor—Topiramate—epilepsy syndrome	3.16e-05	0.000413	CcSEcCtD
Amphetamine—Methamphetamine—ADRA2A—epilepsy syndrome	3.15e-05	0.0173	CrCbGaD
Amphetamine—Vomiting—Lamotrigine—epilepsy syndrome	3.15e-05	0.000413	CcSEcCtD
Amphetamine—Urticaria—Valproic Acid—epilepsy syndrome	3.13e-05	0.00041	CcSEcCtD
Amphetamine—Benzphetamine—ADRA2A—epilepsy syndrome	3.13e-05	0.0172	CrCbGaD
Amphetamine—Rash—Lamotrigine—epilepsy syndrome	3.13e-05	0.00041	CcSEcCtD
Amphetamine—Dermatitis—Lamotrigine—epilepsy syndrome	3.12e-05	0.000409	CcSEcCtD
Amphetamine—Abdominal pain—Valproic Acid—epilepsy syndrome	3.12e-05	0.000408	CcSEcCtD
Amphetamine—Body temperature increased—Valproic Acid—epilepsy syndrome	3.12e-05	0.000408	CcSEcCtD
Amphetamine—Anorexia—Gabapentin—epilepsy syndrome	3.11e-05	0.000408	CcSEcCtD
Amphetamine—Headache—Lamotrigine—epilepsy syndrome	3.11e-05	0.000407	CcSEcCtD
Amphetamine—Decreased appetite—Pregabalin—epilepsy syndrome	3.1e-05	0.000406	CcSEcCtD
Amphetamine—Agitation—Topiramate—epilepsy syndrome	3.09e-05	0.000405	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.08e-05	0.000403	CcSEcCtD
Amphetamine—Fatigue—Pregabalin—epilepsy syndrome	3.07e-05	0.000402	CcSEcCtD
Amphetamine—Nausea—Carbamazepine—epilepsy syndrome	3.05e-05	0.000399	CcSEcCtD
Amphetamine—Constipation—Pregabalin—epilepsy syndrome	3.05e-05	0.000399	CcSEcCtD
Amphetamine—Palpitations—Topiramate—epilepsy syndrome	2.98e-05	0.00039	CcSEcCtD
Amphetamine—Selegiline—CYP2C19—epilepsy syndrome	2.96e-05	0.0163	CrCbGaD
Amphetamine—Insomnia—Gabapentin—epilepsy syndrome	2.95e-05	0.000387	CcSEcCtD
Amphetamine—Nausea—Lamotrigine—epilepsy syndrome	2.95e-05	0.000386	CcSEcCtD
Amphetamine—Convulsion—Topiramate—epilepsy syndrome	2.92e-05	0.000382	CcSEcCtD
Amphetamine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.91e-05	0.000382	CcSEcCtD
Amphetamine—Dyspnoea—Gabapentin—epilepsy syndrome	2.91e-05	0.000381	CcSEcCtD
Amphetamine—Hypertension—Topiramate—epilepsy syndrome	2.91e-05	0.000381	CcSEcCtD
Amphetamine—Somnolence—Gabapentin—epilepsy syndrome	2.9e-05	0.00038	CcSEcCtD
Amphetamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.9e-05	0.00038	CcSEcCtD
Amphetamine—Dyspepsia—Gabapentin—epilepsy syndrome	2.88e-05	0.000377	CcSEcCtD
Amphetamine—Chest pain—Topiramate—epilepsy syndrome	2.87e-05	0.000376	CcSEcCtD
Amphetamine—Anxiety—Topiramate—epilepsy syndrome	2.86e-05	0.000374	CcSEcCtD
Amphetamine—Decreased appetite—Gabapentin—epilepsy syndrome	2.84e-05	0.000372	CcSEcCtD
Amphetamine—Tranylcypromine—CYP2D6—epilepsy syndrome	2.83e-05	0.0155	CrCbGaD
Amphetamine—Urticaria—Pregabalin—epilepsy syndrome	2.83e-05	0.000371	CcSEcCtD
Amphetamine—Asthenia—Valproic Acid—epilepsy syndrome	2.83e-05	0.00037	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.82e-05	0.000369	CcSEcCtD
Amphetamine—Fatigue—Gabapentin—epilepsy syndrome	2.82e-05	0.000369	CcSEcCtD
Amphetamine—Abdominal pain—Pregabalin—epilepsy syndrome	2.82e-05	0.000369	CcSEcCtD
Amphetamine—Body temperature increased—Pregabalin—epilepsy syndrome	2.82e-05	0.000369	CcSEcCtD
Amphetamine—Dry mouth—Topiramate—epilepsy syndrome	2.8e-05	0.000367	CcSEcCtD
Amphetamine—Constipation—Gabapentin—epilepsy syndrome	2.79e-05	0.000366	CcSEcCtD
Amphetamine—Infection—Topiramate—epilepsy syndrome	2.73e-05	0.000358	CcSEcCtD
Amphetamine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.7e-05	0.000353	CcSEcCtD
Amphetamine—Tachycardia—Topiramate—epilepsy syndrome	2.68e-05	0.000351	CcSEcCtD
Amphetamine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.67e-05	0.00035	CcSEcCtD
Amphetamine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.66e-05	0.000348	CcSEcCtD
Amphetamine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.62e-05	0.000344	CcSEcCtD
Amphetamine—Anorexia—Topiramate—epilepsy syndrome	2.62e-05	0.000343	CcSEcCtD
Amphetamine—Phenelzine—CYP2C19—epilepsy syndrome	2.61e-05	0.0143	CrCbGaD
Amphetamine—Dizziness—Valproic Acid—epilepsy syndrome	2.61e-05	0.000341	CcSEcCtD
Amphetamine—Urticaria—Gabapentin—epilepsy syndrome	2.6e-05	0.00034	CcSEcCtD
Amphetamine—Body temperature increased—Gabapentin—epilepsy syndrome	2.58e-05	0.000338	CcSEcCtD
Amphetamine—Abdominal pain—Gabapentin—epilepsy syndrome	2.58e-05	0.000338	CcSEcCtD
Amphetamine—Asthenia—Pregabalin—epilepsy syndrome	2.56e-05	0.000335	CcSEcCtD
Amphetamine—Vomiting—Valproic Acid—epilepsy syndrome	2.51e-05	0.000328	CcSEcCtD
Amphetamine—Insomnia—Topiramate—epilepsy syndrome	2.49e-05	0.000326	CcSEcCtD
Amphetamine—Rash—Valproic Acid—epilepsy syndrome	2.48e-05	0.000325	CcSEcCtD
Amphetamine—Dermatitis—Valproic Acid—epilepsy syndrome	2.48e-05	0.000325	CcSEcCtD
Amphetamine—Headache—Valproic Acid—epilepsy syndrome	2.47e-05	0.000323	CcSEcCtD
Amphetamine—Dyspnoea—Topiramate—epilepsy syndrome	2.45e-05	0.000321	CcSEcCtD
Amphetamine—Somnolence—Topiramate—epilepsy syndrome	2.44e-05	0.00032	CcSEcCtD
Amphetamine—Diarrhoea—Pregabalin—epilepsy syndrome	2.44e-05	0.000319	CcSEcCtD
Amphetamine—Dyspepsia—Topiramate—epilepsy syndrome	2.42e-05	0.000317	CcSEcCtD
Amphetamine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.41e-05	0.000315	CcSEcCtD
Amphetamine—Methamphetamine—SLC6A4—epilepsy syndrome	2.41e-05	0.0132	CrCbGaD
Amphetamine—Decreased appetite—Topiramate—epilepsy syndrome	2.39e-05	0.000313	CcSEcCtD
Amphetamine—Phentermine—CYP2D6—epilepsy syndrome	2.37e-05	0.013	CrCbGaD
Amphetamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.37e-05	0.000311	CcSEcCtD
Amphetamine—Fatigue—Topiramate—epilepsy syndrome	2.37e-05	0.00031	CcSEcCtD
Amphetamine—Dizziness—Pregabalin—epilepsy syndrome	2.36e-05	0.000309	CcSEcCtD
Amphetamine—Constipation—Topiramate—epilepsy syndrome	2.35e-05	0.000308	CcSEcCtD
Amphetamine—Asthenia—Gabapentin—epilepsy syndrome	2.34e-05	0.000307	CcSEcCtD
Amphetamine—Nausea—Valproic Acid—epilepsy syndrome	2.34e-05	0.000307	CcSEcCtD
Amphetamine—Benzyl alcohol—CYP2D6—epilepsy syndrome	2.29e-05	0.0126	CrCbGaD
Amphetamine—Vomiting—Pregabalin—epilepsy syndrome	2.27e-05	0.000297	CcSEcCtD
Amphetamine—Dextroamphetamine—CYP2D6—epilepsy syndrome	2.26e-05	0.0124	CrCbGaD
Amphetamine—Pseudoephedrine—CYP2D6—epilepsy syndrome	2.25e-05	0.0123	CrCbGaD
Amphetamine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.25e-05	0.000294	CcSEcCtD
Amphetamine—Rash—Pregabalin—epilepsy syndrome	2.25e-05	0.000294	CcSEcCtD
Amphetamine—Dermatitis—Pregabalin—epilepsy syndrome	2.24e-05	0.000294	CcSEcCtD
Amphetamine—Diarrhoea—Gabapentin—epilepsy syndrome	2.24e-05	0.000293	CcSEcCtD
Amphetamine—Headache—Pregabalin—epilepsy syndrome	2.23e-05	0.000292	CcSEcCtD
Amphetamine—Selegiline—CYP2D6—epilepsy syndrome	2.2e-05	0.012	CrCbGaD
Amphetamine—Urticaria—Topiramate—epilepsy syndrome	2.18e-05	0.000286	CcSEcCtD
Amphetamine—Body temperature increased—Topiramate—epilepsy syndrome	2.17e-05	0.000285	CcSEcCtD
Amphetamine—Abdominal pain—Topiramate—epilepsy syndrome	2.17e-05	0.000285	CcSEcCtD
Amphetamine—Dizziness—Gabapentin—epilepsy syndrome	2.16e-05	0.000283	CcSEcCtD
Amphetamine—Nausea—Pregabalin—epilepsy syndrome	2.12e-05	0.000277	CcSEcCtD
Amphetamine—Vomiting—Gabapentin—epilepsy syndrome	2.08e-05	0.000272	CcSEcCtD
Amphetamine—Rash—Gabapentin—epilepsy syndrome	2.06e-05	0.00027	CcSEcCtD
Amphetamine—Dermatitis—Gabapentin—epilepsy syndrome	2.06e-05	0.00027	CcSEcCtD
Amphetamine—Headache—Gabapentin—epilepsy syndrome	2.05e-05	0.000268	CcSEcCtD
Amphetamine—Hypersensitivity—Topiramate—epilepsy syndrome	2.02e-05	0.000265	CcSEcCtD
Amphetamine—Asthenia—Topiramate—epilepsy syndrome	1.97e-05	0.000258	CcSEcCtD
Amphetamine—Nateglinide—CYP2D6—epilepsy syndrome	1.96e-05	0.0108	CrCbGaD
Amphetamine—Nausea—Gabapentin—epilepsy syndrome	1.94e-05	0.000254	CcSEcCtD
Amphetamine—Diarrhoea—Topiramate—epilepsy syndrome	1.88e-05	0.000246	CcSEcCtD
Amphetamine—Dizziness—Topiramate—epilepsy syndrome	1.82e-05	0.000238	CcSEcCtD
Amphetamine—Vomiting—Topiramate—epilepsy syndrome	1.75e-05	0.000229	CcSEcCtD
Amphetamine—Rash—Topiramate—epilepsy syndrome	1.73e-05	0.000227	CcSEcCtD
Amphetamine—Dermatitis—Topiramate—epilepsy syndrome	1.73e-05	0.000227	CcSEcCtD
Amphetamine—Headache—Topiramate—epilepsy syndrome	1.72e-05	0.000226	CcSEcCtD
Amphetamine—Methamphetamine—CYP2D6—epilepsy syndrome	1.69e-05	0.00928	CrCbGaD
Amphetamine—Nausea—Topiramate—epilepsy syndrome	1.63e-05	0.000214	CcSEcCtD
Amphetamine—Selegiline—ABCB1—epilepsy syndrome	1.57e-05	0.0086	CrCbGaD
Amphetamine—Nateglinide—ALB—epilepsy syndrome	1.47e-05	0.00806	CrCbGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	3.87e-06	7.67e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCR5—epilepsy syndrome	3.85e-06	7.64e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.84e-06	7.61e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADRA2A—epilepsy syndrome	3.83e-06	7.6e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL2—epilepsy syndrome	3.83e-06	7.6e-05	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.82e-06	7.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OPRM1—epilepsy syndrome	3.82e-06	7.58e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—BCHE—epilepsy syndrome	3.81e-06	7.57e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM2—epilepsy syndrome	3.81e-06	7.57e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—epilepsy syndrome	3.77e-06	7.48e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CRH—epilepsy syndrome	3.73e-06	7.41e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OXT—epilepsy syndrome	3.73e-06	7.41e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL2—epilepsy syndrome	3.73e-06	7.41e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	3.73e-06	7.41e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CA4—epilepsy syndrome	3.73e-06	7.41e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	3.72e-06	7.39e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TXNRD1—epilepsy syndrome	3.7e-06	7.35e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SLC2A1—epilepsy syndrome	3.64e-06	7.22e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR3—epilepsy syndrome	3.61e-06	7.16e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PLCB1—epilepsy syndrome	3.6e-06	7.14e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AQP1—epilepsy syndrome	3.59e-06	7.13e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TH—epilepsy syndrome	3.59e-06	7.12e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AGT—epilepsy syndrome	3.57e-06	7.1e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—HMOX1—epilepsy syndrome	3.54e-06	7.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NPY—epilepsy syndrome	3.51e-06	6.97e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COX3—epilepsy syndrome	3.51e-06	6.97e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CAT—epilepsy syndrome	3.49e-06	6.93e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGF2—epilepsy syndrome	3.46e-06	6.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SSTR3—epilepsy syndrome	3.45e-06	6.84e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCB1—epilepsy syndrome	3.39e-06	6.74e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CRH—epilepsy syndrome	3.39e-06	6.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL3—epilepsy syndrome	3.39e-06	6.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OXT—epilepsy syndrome	3.39e-06	6.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL2—epilepsy syndrome	3.39e-06	6.73e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR2—epilepsy syndrome	3.38e-06	6.7e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SST—epilepsy syndrome	3.38e-06	6.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.37e-06	6.7e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	3.33e-06	6.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	3.33e-06	6.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	3.33e-06	6.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	3.33e-06	6.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	3.33e-06	6.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPY2R—epilepsy syndrome	3.31e-06	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR8—epilepsy syndrome	3.31e-06	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.31e-06	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR9—epilepsy syndrome	3.31e-06	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SSTR1—epilepsy syndrome	3.31e-06	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.3e-06	6.56e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	3.25e-06	6.45e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	3.25e-06	6.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM3—epilepsy syndrome	3.24e-06	6.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM4—epilepsy syndrome	3.24e-06	6.43e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RELA—epilepsy syndrome	3.21e-06	6.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DUSP4—epilepsy syndrome	3.18e-06	6.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SSTR2—epilepsy syndrome	3.18e-06	6.32e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.17e-06	6.3e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.17e-06	6.3e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GPX1—epilepsy syndrome	3.16e-06	6.26e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MTOR—epilepsy syndrome	3.15e-06	6.25e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR1—epilepsy syndrome	3.12e-06	6.18e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.1e-06	6.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM8—epilepsy syndrome	3.07e-06	6.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PGF—epilepsy syndrome	3.07e-06	6.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR2—epilepsy syndrome	3.07e-06	6.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SST—epilepsy syndrome	3.07e-06	6.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	3.04e-06	6.04e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	3.04e-06	6.04e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	3.04e-06	6.04e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR7—epilepsy syndrome	3.04e-06	6.03e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—epilepsy syndrome	3.01e-06	5.97e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADRA2A—epilepsy syndrome	3e-06	5.96e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HMOX1—epilepsy syndrome	2.99e-06	5.94e-05	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.98e-06	5.92e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CAT—epilepsy syndrome	2.95e-06	5.86e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL2—epilepsy syndrome	2.94e-06	5.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OPRD1—epilepsy syndrome	2.93e-06	5.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNAO1—epilepsy syndrome	2.93e-06	5.82e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	2.93e-06	5.81e-05	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.92e-06	5.8e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT3—epilepsy syndrome	2.9e-06	5.75e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CASP3—epilepsy syndrome	2.9e-06	5.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL12—epilepsy syndrome	2.88e-06	5.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.88e-06	5.72e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCB1—epilepsy syndrome	2.87e-06	5.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR1—epilepsy syndrome	2.83e-06	5.62e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	2.83e-06	5.61e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	2.83e-06	5.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PLCB1—epilepsy syndrome	2.82e-06	5.6e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—JUN—epilepsy syndrome	2.81e-06	5.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CHRM1—epilepsy syndrome	2.81e-06	5.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM1—epilepsy syndrome	2.81e-06	5.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDYN—epilepsy syndrome	2.81e-06	5.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR7—epilepsy syndrome	2.81e-06	5.58e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AGT—epilepsy syndrome	2.77e-06	5.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR7—epilepsy syndrome	2.76e-06	5.48e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—epilepsy syndrome	2.74e-06	5.43e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOE—epilepsy syndrome	2.71e-06	5.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HBEGF—epilepsy syndrome	2.68e-06	5.32e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GPX1—epilepsy syndrome	2.67e-06	5.3e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	2.66e-06	5.28e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AKT1—epilepsy syndrome	2.65e-06	5.27e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	2.65e-06	5.26e-05	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.64e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CDC42—epilepsy syndrome	2.64e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GFAP—epilepsy syndrome	2.64e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GAL—epilepsy syndrome	2.64e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT3—epilepsy syndrome	2.63e-06	5.22e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM5—epilepsy syndrome	2.61e-06	5.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP2—epilepsy syndrome	2.61e-06	5.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CHRM3—epilepsy syndrome	2.61e-06	5.19e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	2.59e-06	5.14e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	2.58e-06	5.13e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	2.57e-06	5.09e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AVP—epilepsy syndrome	2.56e-06	5.08e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SRC—epilepsy syndrome	2.52e-06	5.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	2.52e-06	5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	2.52e-06	5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CX3CR1—epilepsy syndrome	2.51e-06	4.97e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.46e-06	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CX3CL1—epilepsy syndrome	2.46e-06	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CHRM2—epilepsy syndrome	2.46e-06	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BDKRB1—epilepsy syndrome	2.46e-06	4.88e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	2.41e-06	4.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	2.41e-06	4.77e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CDC42—epilepsy syndrome	2.4e-06	4.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GABBR1—epilepsy syndrome	2.39e-06	4.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	2.35e-06	4.67e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AGT—epilepsy syndrome	2.34e-06	4.65e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—epilepsy syndrome	2.33e-06	4.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AVP—epilepsy syndrome	2.32e-06	4.61e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	2.32e-06	4.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	2.31e-06	4.58e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOE—epilepsy syndrome	2.29e-06	4.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRH3—epilepsy syndrome	2.29e-06	4.55e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	2.26e-06	4.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	2.26e-06	4.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	2.22e-06	4.41e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	2.2e-06	4.38e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—BCHE—epilepsy syndrome	2.2e-06	4.36e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	2.18e-06	4.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	2.13e-06	4.23e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.13e-06	4.23e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—epilepsy syndrome	2.12e-06	4.22e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	2.09e-06	4.16e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.08e-06	4.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPY—epilepsy syndrome	2.08e-06	4.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	2.08e-06	4.12e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	2.07e-06	4.11e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TH—epilepsy syndrome	2.06e-06	4.1e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	2.02e-06	4.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.02e-06	4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	2e-06	3.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	2e-06	3.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OXT—epilepsy syndrome	2e-06	3.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	2e-06	3.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRH—epilepsy syndrome	2e-06	3.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	1.98e-06	3.92e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—epilepsy syndrome	1.97e-06	3.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.93e-06	3.84e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.87e-06	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	1.86e-06	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	1.86e-06	3.7e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—epilepsy syndrome	1.86e-06	3.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	1.83e-06	3.64e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.82e-06	3.62e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.82e-06	3.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	1.81e-06	3.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	1.81e-06	3.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SST—epilepsy syndrome	1.81e-06	3.59e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—epilepsy syndrome	1.8e-06	3.57e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	1.8e-06	3.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.77e-06	3.52e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	1.76e-06	3.5e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.72e-06	3.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.7e-06	3.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	1.7e-06	3.38e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	1.7e-06	3.37e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.7e-06	3.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.7e-06	3.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.69e-06	3.35e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	1.67e-06	3.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	1.67e-06	3.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	1.67e-06	3.31e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.65e-06	3.28e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	1.63e-06	3.24e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	1.58e-06	3.14e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	1.57e-06	3.12e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—epilepsy syndrome	1.57e-06	3.11e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	1.55e-06	3.08e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	1.54e-06	3.06e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.54e-06	3.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	1.52e-06	3.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	1.51e-06	3e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.49e-06	2.95e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.45e-06	2.87e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.44e-06	2.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	1.44e-06	2.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	1.42e-06	2.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	1.42e-06	2.81e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	1.37e-06	2.72e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.35e-06	2.68e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.32e-06	2.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	1.3e-06	2.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	1.26e-06	2.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	1.26e-06	2.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	1.26e-06	2.49e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.24e-06	2.45e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.23e-06	2.44e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.21e-06	2.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.2e-06	2.38e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.17e-06	2.33e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.17e-06	2.32e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.16e-06	2.31e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.16e-06	2.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.14e-06	2.27e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.13e-06	2.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.08e-06	2.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.08e-06	2.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.06e-06	2.11e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1.04e-06	2.06e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.03e-06	2.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1e-06	1.99e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	9.97e-07	1.98e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	9.66e-07	1.92e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	9.53e-07	1.89e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—epilepsy syndrome	9.34e-07	1.85e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	9.27e-07	1.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	9.12e-07	1.81e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	9.05e-07	1.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	8.92e-07	1.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	8.62e-07	1.71e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	8.07e-07	1.6e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—epilepsy syndrome	7.9e-07	1.57e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	7.56e-07	1.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	7.49e-07	1.49e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.41e-07	1.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	7.34e-07	1.46e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.82e-07	1.35e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.75e-07	1.34e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.56e-07	1.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	6.38e-07	1.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.36e-07	1.26e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	6.19e-07	1.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.88e-07	1.17e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	5.8e-07	1.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.73e-07	1.14e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.08e-07	1.01e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	4.55e-07	9.03e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.66e-07	7.26e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.55e-07	5.06e-06	CbGpPWpGaD
